How Cialis Affects Blood Pressure: Drops and Drug Risks

Cialis (tadalafil) lowers blood pressure by a modest but real amount, typically around 5 mmHg systolic and 3 mmHg diastolic in people with high blood pressure, and somewhat less in healthy individuals. For most people, this dip is clinically harmless. The real danger lies not in the drug’s solo effect on blood pressure but in its interactions with specific medications, particularly nitrates, where the combination can cause a sudden, severe drop that becomes a medical emergency.

How Much Blood Pressure Actually Drops

The blood pressure effect of tadalafil depends heavily on who is taking it. In healthy people without hypertension, a single 20 mg dose produces almost no meaningful change in standing blood pressure compared to a placebo. One study found the average drop was less than 1 mmHg for systolic pressure, with no change in heart rate.¹

In people who already have high blood pressure, the picture shifts. A study using 24-hour ambulatory blood pressure monitoring found that a single 20 mg tadalafil dose reduced systolic pressure by about 5 mmHg and diastolic by about 3 mmHg compared to placebo. Among a subgroup whose blood pressure was poorly controlled despite taking two to four antihypertensive medications, the drop was larger: roughly 7.5 mmHg systolic and 4.3 mmHg diastolic.² That pattern makes intuitive sense: if your vessels are already tighter, a drug that relaxes them has more room to work.

For people on antihypertensive medications more generally, phase 3 clinical trials found that tadalafil produced only mild additional blood pressure reductions, with no statistically significant differences from placebo in average blood pressure changes even among patients on two or more classes of blood pressure drugs.³ So for most people already managing their hypertension, tadalafil at standard doses is unlikely to cause a noticeable or dangerous additional drop.

Why the Drop Happens

Tadalafil belongs to a class of drugs called PDE5 inhibitors. PDE5 is an enzyme that breaks down a signaling molecule called cyclic GMP, which tells smooth muscle cells lining blood vessel walls to relax. When tadalafil blocks PDE5, cyclic GMP accumulates, smooth muscle relaxes, and blood vessels widen. Wider vessels mean less resistance to blood flow, and lower resistance means lower blood pressure. This is the same mechanism that produces an erection (more blood flow into the penis) and the same mechanism that makes the drug useful in pulmonary hypertension (less resistance in lung blood vessels).

The effect is systemic, meaning it happens throughout the body, not just in one organ. That is why blood pressure drops at all. But PDE5 is not evenly distributed everywhere, and the concentrations of the enzyme are highest in specific vascular beds like the lungs and the penis. The systemic blood pressure effect is therefore relatively mild compared to the targeted effects on those tissues.

The Nitrate Rule

If there is one drug interaction every Cialis user must know about, it is the nitrate interaction. Nitrates, prescribed for chest pain (angina), include drugs like nitroglycerin (sublingual tablets or spray), isosorbide mononitrate, and isosorbide dinitrate. These medications work by increasing nitric oxide, which also raises cyclic GMP levels. Combine a nitrate with a PDE5 inhibitor and you get a double dose of the same vasodilating pathway, producing a severe and potentially life-threatening drop in blood pressure.

What makes tadalafil especially tricky compared to other PDE5 inhibitors is its long half-life. The drug stays active in the body much longer than sildenafil or vardenafil. Research on the timing of the tadalafil-nitrate interaction found that the dangerous blood pressure drop lasted a full 24 hours after a tadalafil dose. By 48 hours, the interaction was no longer detectable.⁴ This means that if you take tadalafil on a Friday evening and develop chest pain on Saturday afternoon, using nitroglycerin could be dangerous. Emergency room doctors need to know you have taken it so they can use alternative treatments for the chest pain.

Recreational “poppers” (amyl nitrite and butyl nitrite) are also nitrates. They carry the same risk. The combination has caused deaths, and the danger is not theoretical or dose-dependent in a predictable way. The absolute rule is simple: tadalafil and any form of nitrate should never overlap in your system.

Alpha-Blockers and Which Ones Matter

Alpha-blockers are commonly prescribed for an enlarged prostate (benign prostatic hyperplasia, or BPH) and sometimes for high blood pressure. They relax smooth muscle too, but through a different pathway, by blocking alpha-adrenergic receptors. When combined with tadalafil, the concern is additive blood pressure lowering and a risk of orthostatic hypotension, the kind of dizziness or lightheadedness you get when standing up.

Not all alpha-blockers carry equal risk. The interaction varies dramatically depending on which alpha-blocker you take. In a study of healthy men, tadalafil 20 mg combined with doxazosin produced an average additional drop of about 10 mmHg in standing systolic blood pressure beyond what doxazosin alone caused. Over a quarter of participants on the combination had their standing systolic pressure fall below 85 mmHg, compared to only 6% on doxazosin with placebo. Tamsulosin, however, was a different story: adding tadalafil (at either 10 or 20 mg) produced drops of only about 2 mmHg beyond placebo, and no participant’s standing systolic pressure fell below 85 mmHg.⁵

Silodosin, another alpha-blocker that is highly selective for the alpha-1a receptor subtype found in the prostate, showed a similarly reassuring profile. When combined with tadalafil, there were no significant orthostatic changes in blood pressure or heart rate, and no participants experienced symptoms of low blood pressure.⁶

The pattern here is that alpha-blockers selective for the prostate (tamsulosin, silodosin) play much better with PDE5 inhibitors than non-selective alpha-blockers like doxazosin, which relax blood vessels body-wide. If your doctor is prescribing both an alpha-blocker for urinary symptoms and tadalafil for erectile dysfunction or BPH, the choice of alpha-blocker matters a great deal. This is a conversation worth having explicitly with your prescriber, because a swap from doxazosin to tamsulosin could be the difference between routine treatment and passing out when you stand up.

Exercise and the Heart

A common concern for men with heart disease is whether tadalafil makes physical exertion riskier. Sexual activity itself puts some demand on the heart, and adding a blood-pressure-lowering drug to the mix sounds like it could be a problem. The evidence on this is reassuring.

In a study of men with documented coronary artery disease, tadalafil did not shorten the time it took for exercise to provoke signs of reduced blood flow to the heart. Participants completed treadmill tests that were essentially identical in duration whether they had taken tadalafil or a placebo. Blood pressure was lower at rest, during exercise, and after exercise in the tadalafil group (by about 7 to 13 mmHg systolic at various time points), but this did not translate into earlier signs of cardiac stress.⁷

Separate research using imaging to measure actual blood flow through the heart muscle found that tadalafil had no significant effect on resting myocardial blood flow or on blood flow during pharmacological stress in patients with coronary artery disease. In segments of the heart with normal blood supply, there was actually a small increase in blood flow during dobutamine-induced stress when tadalafil was on board, though the effect was modest.⁸

The takeaway is that tadalafil lowers blood pressure during exercise but does not appear to starve the heart of blood or create a new ischemic threshold. That said, these studies were done in controlled settings with patients who had stable coronary disease. Someone with unstable angina, recent heart attack, or very low baseline blood pressure is in a different risk category, and the drug is not appropriate in those situations.

Cialis for Pulmonary Hypertension

Tadalafil’s blood-pressure-lowering effect is not always a side effect to be managed. In pulmonary arterial hypertension (PAH), where the blood vessels in the lungs become abnormally constricted, lowering pressure in the pulmonary circulation is exactly the goal. Tadalafil is marketed under the brand name Adcirca for this indication, at a higher daily dose (40 mg) than the typical erectile dysfunction dose.

Studies of tadalafil in PAH have shown improvements in stroke volume and cardiac output, along with decreased pulmonary vascular resistance. In patients with PAH associated with systemic sclerosis, there was also a measurable decrease in mean pulmonary artery pressure.⁹ The drug essentially offloads the right side of the heart by making it easier for blood to flow through the lungs.

One wrinkle worth noting: patients with PAH who take tadalafil at the 40 mg dose will experience greater systemic blood pressure effects than someone taking the 5 or 20 mg erectile dysfunction dose. Prescribers managing PAH need to account for both the desired pulmonary effect and the accompanying systemic drop, especially in patients who may already have low systemic blood pressure from right heart failure.

Vascular Health Beyond Blood Pressure Numbers

Tadalafil’s effects on blood vessels go beyond simply widening them in the moment. Daily low-dose tadalafil (5 mg) has been shown to improve markers of vascular health. In men with BPH, daily tadalafil improved brachial-ankle pulse wave velocity, a measure of arterial stiffness. Faster pulse wave velocity means stiffer arteries, so a decrease suggests the vessels became more elastic.¹⁰ This is interesting because arterial stiffness is itself a risk factor for cardiovascular events, independent of blood pressure.

Whether tadalafil actually improves blood flow in the prostate and bladder, as you might expect from a vasodilating drug, is less clear. A randomized, placebo-controlled trial measuring blood flow in the prostate and bladder neck using Doppler ultrasound found no detectable improvement after eight weeks of daily tadalafil in men with BPH. The researchers speculated that baseline blood flow may have already been near normal, that the imaging technique was not sensitive enough, or that tadalafil’s benefit in BPH comes from mechanisms other than improved pelvic blood flow.¹¹

Animal research has suggested tadalafil may protect kidney function in the setting of chronic kidney disease. In a rat model with high-salt-induced kidney damage, tadalafil reduced serum creatinine (a marker of kidney function) and urinary protein (a marker of kidney damage), with higher doses also lowering blood pressure.¹² This line of research is still preliminary and has not translated into clinical recommendations for kidney patients, but it suggests the drug’s vascular effects may confer organ-protective benefits beyond what the blood pressure numbers alone would predict.

Who Feels the Drop Most

The magnitude of blood pressure reduction from tadalafil is not uniform across all users. The ambulatory monitoring study discussed earlier is instructive: the people with the biggest drops were those whose blood pressure was already poorly controlled on multiple medications. Their systolic pressure fell by roughly 7.5 mmHg on average, compared to about 5 mmHg in the broader hypertensive group.² The pattern suggests that people with stiffer, more constricted vasculature have more to “give” when a vasodilator comes along.

Older adults tend to have stiffer arteries, higher baseline blood pressure, and more comorbidities requiring multiple medications, all of which could amplify the blood pressure effect. They are also more prone to orthostatic hypotension for other reasons (reduced baroreceptor sensitivity, dehydration, autonomic changes). Combining tadalafil with a full medicine cabinet in a 75-year-old is a different calculation than prescribing it to a 40-year-old with no other medications.

Volume status matters too. Someone who is dehydrated from illness, diuretic use, or poor fluid intake will have less circulating blood volume to begin with. Adding a vasodilator to an already underfilled vascular system drops pressure faster and further. The practical advice here is pedestrian but important: stay well-hydrated, especially when starting tadalafil or increasing the dose, and get up slowly from sitting or lying down if you are on any combination of blood-pressure-affecting medications.

What Chronic Use May Do to the Eyes

PDE5 is also expressed in the retina, and there has been long-standing interest in whether chronic PDE5 inhibitor use affects vision. The most commonly reported visual side effect with this drug class is a mild, transient blue tint to vision, more associated with sildenafil than tadalafil. But animal research has raised questions about deeper retinal effects from sustained use.

A study examining rat retinas after chronic tadalafil exposure found reduced retinal thickness, fewer cells in both the outer and inner nuclear layers, dilated blood capillaries in the retinal tissue, and a decline in ganglion cells. The researchers concluded that prolonged PDE5 inhibition could induce degenerative changes in retinal neurons, though the changes appeared to be reversible.¹³

The relevance to humans is uncertain. Rat studies use doses and durations that do not directly translate to human prescribing, and the retinal findings have not been clearly replicated in large human trials. Still, the observation that vascular changes from PDE5 inhibition can reach the eye is worth noting for anyone on long-term daily tadalafil, particularly those with pre-existing retinal conditions or other risk factors for eye disease like diabetes. Regular eye exams are reasonable for anyone on chronic use, even if the evidence for harm in humans remains thin.